BPaL(M) Regimen for the Treatment of MDR/RR-TB

NCT05381194 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Multidrug- and Rifampicin-resistant Tuberculosis

Interventions

DRUG: BPaL(M) regimen

Sponsor

Asan Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]